WNT5A-mediated β-catenin-independent signalling is a novel regulator of cancer cell metabolism

Victoria Sherwood, Shivendra Kumar Chaurasiya, Elin J Ekström, William Guilmain, Qing Liu, Thomas Koeck, Kate Brown, Karin Hansson, Margrét Agnarsdóttir, Michael Bergqvist, Karin Jirström, Fredrik Ponten, Peter James, Tommy Andersson

    Research output: Contribution to journalArticlepeer-review

    43 Citations (Scopus)

    Abstract

    WNT5A has been identified as an important ligand in the malignant progression of a number of tumours. Although WNT5A signalling is often altered in cancer, the ligand(')s role as either a tumour suppressor or oncogene varies between tumour types and is a contemporary issue for investigators of β-catenin (CTNNB1)-independent WNT signalling in oncology. Here we report that one of the initial effects of active WNT5A signalling in malignant melanoma cells is an alteration in cellular energy metabolism and specifically an increase in aerobic glycolysis. This was found to be at least in part due to an increase in active Akt signalling and lactate dehydrogenase (LDH) activity. The clinical relevance of these findings was strengthened by a strong correlation (p
    Original languageEnglish
    Pages (from-to)784-794
    Number of pages11
    JournalCarcinogenesis
    Volume35
    Issue number4
    Early online date30 Nov 2013
    DOIs
    Publication statusPublished - 2014

    Cite this